E74‐like ETS transcription factor 3 expression and regulation in human intervertebral disc

Abstract Background Intervertebral disc degeneration (IVDD) is one of the main causes of chronic low back pain. The degenerative process is often initiated by an imbalance between catabolic and anabolic pathways. Despite the large socio‐economic impact, the initiation and progress of disc degenerati...

Full description

Saved in:
Bibliographic Details
Main Authors: María González‐Rodríguez, Djedjiga Ait Eldjoudi, Alfonso Cordero‐Barreal, Mariam Farrag, María Varela‐García, Clara Ruiz‐Fernández, Carlos Torrijos‐Pulpón, Francisca Lago, Lucía García‐Caballero, Yousof Farrag, Javier Conde‐Aranda, Jesus Pino, Oreste Gualillo
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:JOR Spine
Subjects:
Online Access:https://doi.org/10.1002/jsp2.70016
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324315103723520
author María González‐Rodríguez
Djedjiga Ait Eldjoudi
Alfonso Cordero‐Barreal
Mariam Farrag
María Varela‐García
Clara Ruiz‐Fernández
Carlos Torrijos‐Pulpón
Francisca Lago
Lucía García‐Caballero
Yousof Farrag
Javier Conde‐Aranda
Jesus Pino
Oreste Gualillo
author_facet María González‐Rodríguez
Djedjiga Ait Eldjoudi
Alfonso Cordero‐Barreal
Mariam Farrag
María Varela‐García
Clara Ruiz‐Fernández
Carlos Torrijos‐Pulpón
Francisca Lago
Lucía García‐Caballero
Yousof Farrag
Javier Conde‐Aranda
Jesus Pino
Oreste Gualillo
author_sort María González‐Rodríguez
collection DOAJ
description Abstract Background Intervertebral disc degeneration (IVDD) is one of the main causes of chronic low back pain. The degenerative process is often initiated by an imbalance between catabolic and anabolic pathways. Despite the large socio‐economic impact, the initiation and progress of disc degeneration are poorly understood. Although intervertebral disc (IVD) and articular joint are not identical, their degenerative roads are remarkably similar. We, and another authors, previously demonstrated that E‐74‐like factor 3 (ELF3), a transcription factor induced by inflammatory mediators in various cell types including chondrocytes, is a central contributing factor for cartilage degradation. Thus, we aim to explore, for the first time, the expression, modulation, and the role of ELF3 in human IVD cells. Methods The presence of ELF3 in healthy and degenerated IVD tissues was initially determined by immunohistochemistry in annulus fibrosus (AF) and nucleus pulposus (NP). mRNA and protein expression were measured, respectively, by RT‐qPCR and Western blot in AF and NP IVD cells harvested from healthy individuals and IVDD patients. Overexpression of ELF3 was performed by transfection of AF IVDD cells with pESE‐1: ELF3 expression vector or pCI: empty vector. Results Our results unveiled, for the first time, the expression of ELF3 in IVD tissues. ELF3 is notably upregulated in degenerated tissues compared to those from healthy patients. In addition, the stimulation of IVDD AF cells with various proinflammatory stimuli, showed marked increase in both mRNA and protein expression of ELF3. ELF3 overexpression in AF IVDD cells resulted in the upregulation of proinflammatory and catabolic genes such as PTGS2, NOS2, LCN2, IL‐6, MMP13, and ADAMTS‐5; whereas, ELF3 silencing resulted in the opposite results. Conclusions Our results support a novel role for ELF3 as a pro‐inflammatory and pro‐catabolic transcriptional mediator, whose targeting in IVD tissues might be of potential therapeutic relevance in disc degeneration.
format Article
id doaj-art-592d1a811ca74219a0a555a92654dabc
institution Kabale University
issn 2572-1143
language English
publishDate 2025-03-01
publisher Wiley
record_format Article
series JOR Spine
spelling doaj-art-592d1a811ca74219a0a555a92654dabc2025-08-20T03:48:45ZengWileyJOR Spine2572-11432025-03-0181n/an/a10.1002/jsp2.70016E74‐like ETS transcription factor 3 expression and regulation in human intervertebral discMaría González‐Rodríguez0Djedjiga Ait Eldjoudi1Alfonso Cordero‐Barreal2Mariam Farrag3María Varela‐García4Clara Ruiz‐Fernández5Carlos Torrijos‐Pulpón6Francisca Lago7Lucía García‐Caballero8Yousof Farrag9Javier Conde‐Aranda10Jesus Pino11Oreste Gualillo12SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainMolecular and Cellular Cardiology Group, SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), Research Laboratory 7 Santiago University Clinical Hospital Santiago de Compostela SpainDepartment of Morphological Sciences. School of Medicine and Dentistry University of Santiago de Compostela Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainMolecular and Cellular Gastroenterology Health Research Institute of Santiago de Compostela (IDIS) Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainSERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), The NEIRID Group (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases) Santiago University Clinical Hospital Santiago de Compostela SpainAbstract Background Intervertebral disc degeneration (IVDD) is one of the main causes of chronic low back pain. The degenerative process is often initiated by an imbalance between catabolic and anabolic pathways. Despite the large socio‐economic impact, the initiation and progress of disc degeneration are poorly understood. Although intervertebral disc (IVD) and articular joint are not identical, their degenerative roads are remarkably similar. We, and another authors, previously demonstrated that E‐74‐like factor 3 (ELF3), a transcription factor induced by inflammatory mediators in various cell types including chondrocytes, is a central contributing factor for cartilage degradation. Thus, we aim to explore, for the first time, the expression, modulation, and the role of ELF3 in human IVD cells. Methods The presence of ELF3 in healthy and degenerated IVD tissues was initially determined by immunohistochemistry in annulus fibrosus (AF) and nucleus pulposus (NP). mRNA and protein expression were measured, respectively, by RT‐qPCR and Western blot in AF and NP IVD cells harvested from healthy individuals and IVDD patients. Overexpression of ELF3 was performed by transfection of AF IVDD cells with pESE‐1: ELF3 expression vector or pCI: empty vector. Results Our results unveiled, for the first time, the expression of ELF3 in IVD tissues. ELF3 is notably upregulated in degenerated tissues compared to those from healthy patients. In addition, the stimulation of IVDD AF cells with various proinflammatory stimuli, showed marked increase in both mRNA and protein expression of ELF3. ELF3 overexpression in AF IVDD cells resulted in the upregulation of proinflammatory and catabolic genes such as PTGS2, NOS2, LCN2, IL‐6, MMP13, and ADAMTS‐5; whereas, ELF3 silencing resulted in the opposite results. Conclusions Our results support a novel role for ELF3 as a pro‐inflammatory and pro‐catabolic transcriptional mediator, whose targeting in IVD tissues might be of potential therapeutic relevance in disc degeneration.https://doi.org/10.1002/jsp2.70016catabolismE74‐like ETS transcription factor 3ETS transcription factorshuman intervertebral discinflammationIVDD
spellingShingle María González‐Rodríguez
Djedjiga Ait Eldjoudi
Alfonso Cordero‐Barreal
Mariam Farrag
María Varela‐García
Clara Ruiz‐Fernández
Carlos Torrijos‐Pulpón
Francisca Lago
Lucía García‐Caballero
Yousof Farrag
Javier Conde‐Aranda
Jesus Pino
Oreste Gualillo
E74‐like ETS transcription factor 3 expression and regulation in human intervertebral disc
JOR Spine
catabolism
E74‐like ETS transcription factor 3
ETS transcription factors
human intervertebral disc
inflammation
IVDD
title E74‐like ETS transcription factor 3 expression and regulation in human intervertebral disc
title_full E74‐like ETS transcription factor 3 expression and regulation in human intervertebral disc
title_fullStr E74‐like ETS transcription factor 3 expression and regulation in human intervertebral disc
title_full_unstemmed E74‐like ETS transcription factor 3 expression and regulation in human intervertebral disc
title_short E74‐like ETS transcription factor 3 expression and regulation in human intervertebral disc
title_sort e74 like ets transcription factor 3 expression and regulation in human intervertebral disc
topic catabolism
E74‐like ETS transcription factor 3
ETS transcription factors
human intervertebral disc
inflammation
IVDD
url https://doi.org/10.1002/jsp2.70016
work_keys_str_mv AT mariagonzalezrodriguez e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT djedjigaaiteldjoudi e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT alfonsocorderobarreal e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT mariamfarrag e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT mariavarelagarcia e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT clararuizfernandez e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT carlostorrijospulpon e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT franciscalago e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT luciagarciacaballero e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT yousoffarrag e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT javiercondearanda e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT jesuspino e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc
AT orestegualillo e74likeetstranscriptionfactor3expressionandregulationinhumanintervertebraldisc